OXYCODONE AND ACETAMINOPHEN

Post-LOE

oxycodone and acetaminophen

Ascentage Pharma

ANDAORALTABLET

Approved

Feb 2018

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

3/8 — Basic

OXYCODONE AND ACETAMINOPHEN (oxycodone and acetaminophen) by Ascentage Pharma is full opioid agonists [moa]. Approved for pain severe enough to require an opioid analgesic, for which alternative treatments are inadequate. First approved in 2018.

Drug data last refreshed 23h ago

Mechanism of Action

Full Opioid Agonists

Pharmacologic Class:

Opioid Agonist

Indications (2)

pain severe enough to require an opioid analgesic for which alternative treatments are inadequate

Worked on OXYCODONE AND ACETAMINOPHEN at Ascentage Pharma? Share your interview experience or compensation data (+7 days Pro)

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.